Technical Support
(877) SEPAX-US, press 3      
TechSupport@sepax-tech.com

Representative Literature References

Click a row to open its literature reference.
Product PN Separation Mode
Broad Sample Type Specific Sample
Previous   1   2   3   4   5   6   7   8   9   10   11   12   13   14   15   16   17   18   19   20   21   22   View All
Year Product PN Sep. Mode Broad Sample Category Specific Sample Title
2012Zenix SEC-300N/ASECAntibodyN/AAglycosylated antibodies and antibody fragments produced in a scalable in vitro transcription-translation system
mAbs, Volume 4, Issue 2, pages 217-225
2012Zenix SEC-300N/ASECProteinN/AAccurate retention time determination of co-eluting proteins in analytical chromatography by means of spectral data
Biotechnology and Bioengineering, Volume 110, Issue 3, pages 683-693,
2011SRT SEC-150215150-7825SECProteinProteinHigh-throughput protein purification and quality assessment for crystallization
Methods Volume 55, Issue 1, September 2011, Pages 12-28
2011Nanofilm SEC-250N/ASECProteinN/AAn enzyme from the earthworm Eisenia fetida is not only a protease but also a deoxyribonuclease
Biochemical and Biophysical Research Communications 407 (2011) 113–117
2011Nanofilm SEC-150N/ASEC2-AA Labeled Glycan Standards, OthersN/APorcine dentin sialoprotein glycosylation and glycosaminoglycan attachments
BMC biochemistry
2011Zenix SEC-300N/ASECAntibodyN/AAntibody solubility behavior in monovalent salt solutions reveals specific anion effects at low ionic strength
Journal of Pharmaceutical Sciences, Volume 101, Issue 3, pages 965-977
2008Nanofilm SEC-250N/ASECGPCR, Membrane ProteinN/AStabilization of the β2-adrenergic Receptor 4-3-5 Helix Interface by Mutagenesis of Glu-1223.41, A Critical Residue in GPCR Structure
J Mol Biol. 2008 March 7; 376(5): 1305–1319
Previous   1   2   3   4   5   6   7   8   9   10   11   12   13   14   15   16   17   18   19   20   21   22   View All
© 2024 Sepax Technologies, Inc. All Rights Reserved.